Package 62332-661-05

{"route": ["OPHTHALMIC"], "spl_id": "66c10580-37cc-4061-ac10-1474ba0e60b8", "openfda": {"unii": ["4S9CL2DY2H"], "rxcui": ["861208"], "spl_set_id": ["a52b2033-0333-4630-9b1f-e22918b0962c"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (62332-661-05)  / 5 mL in 1 BOTTLE", "package_ndc": "62332-661-05", "marketing_start_date": "20230329"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (62332-661-10)  / 10 mL in 1 BOTTLE", "package_ndc": "62332-661-10", "marketing_start_date": "20230329"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (62332-661-15)  / 15 mL in 1 BOTTLE", "package_ndc": "62332-661-15", "marketing_start_date": "20230329"}], "brand_name": "Brimonidine Tartrate ophthalmic solution, 0.15%", "product_id": "62332-661_66c10580-37cc-4061-ac10-1474ba0e60b8", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "62332-661", "generic_name": "Brimonidine Tartrate ophthalmic solution, 0.15%", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Brimonidine Tartrate ophthalmic solution, 0.15%", "active_ingredients": [{"name": "BRIMONIDINE TARTRATE", "strength": "1.5 mg/mL"}], "application_number": "ANDA215225", "marketing_category": "ANDA", "marketing_start_date": "20230329", "listing_expiration_date": "20261231"}